Alerts will be sent to your verified email
Verify EmailREGENTRP
Regent Enterprises
|
Rubra Medicaments
|
Lypsa Gems
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-0.22 % | -2.03 % | -27.7 % |
5yr average Equity Multiplier
|
1.83 | 1.44 | 2.37 |
5yr Average Asset Turnover Ratio
|
9.16 | 1.44 | 0.4 |
5yr Avg Net Profit Margin
|
-0.01 % | -0.31 % | -132.74 % |
Price to Book
|
0.5 | 35.84 | 1.21 |
P/E
|
11.97 | 223.95 | 0.0 |
5yr Avg Cash Conversion Cycle
|
14.86 Days | 183.71 Days | 1910.48 Days |
Inventory Days
|
7.65 Days | 0.0 | 17.1 Days |
Days Receivable
|
26.27 Days | 183.71 Days | 3586.85 Days |
Days Payable
|
15.97 Days | 33.56 Days | 2006.22 Days |
5yr Average Interest Coverage Ratio
|
0.2 | -248.31 | 54.4 |
5yr Avg ROCE
|
-0.21 % | -2.28 % | -27.35 % |
5yr Avg Operating Profit Margin
|
-0.17 % | -0.3 % | -64.99 % |
5 yr average Debt to Equity
|
0.0 | 0.06 | 0.16 |
5yr CAGR Net Profit
|
n/a | 0.0 | n/a |
5yr Average Return on Assets
|
-0.02 % | -1.63 % | -13.21 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 0.0 | 36.37 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-1.12 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Regent Enterprises
|
Rubra Medicaments
|
Lypsa Gems
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|